Facebook Pixel Quantum Sensing and Healthcare: Charting India's Next Frontier | Bio Spectrum - business - Lees dit verhaal op Magzter.com

Poging GOUD - Vrij

Quantum Sensing and Healthcare: Charting India's Next Frontier

Bio Spectrum

|

August 2025

Quantum sensing can revolutionise healthcare by enabling early disease detection, precise diagnostics, and customized treatment plans. It detects subtle changes in fields, improving diagnoses for various diseases.

- Ravi Puvvala, MD, Quantum Biosciences Private Limited, India

Quantum Sensing and Healthcare: Charting India's Next Frontier

Technological advances in controlling the world of the ultra-small, made over the past few decades, have brought to fruition a field called “Quantum Sensing.” While it has applicability in a wide variety of problems, medical-diagnostics and healthcare-innovation would be revolutionised. Quantum sensors are ultrasensitive devices, capable of detecting the faintest of biological signals—be they magnetic, electric, thermal or even mechanical. They could enable game-changing applications in real-time diagnostics by detecting or measuring phenomena within single cells that were previously undetectable.

With a strategic investment in research, infrastructure, and translational pathways, India is today presented with a golden opportunity to play a leading role in this emerging domain, radically improving healthcare outcomes and building a global leadership in healthcare technologies.

National Quantum Mission: Catalysing Quantum Healthcare

India's National Quantum Mission (NQM), anchored in T-hubs like Indian Institute of Science (IISc) Bengaluru, Indian Institute of Technology (IIT) Madras, IIT Mumbai, IIT Delhi, has laid the groundwork for innovation across several domains in the field of Quantum Technology. To unlock the full potential for a revolutionary impact on healthcare, the NQM ought to give a high priority to the utilisation of quantum sensing for the biomedical field. A few example applications might include NV center-based subcellular imaging, optically pumped magnetometer (OPM)-driven brain scans, and quantum sensors for tissue oxygenation and metabolism etc. A clearly developed roadmap involving partnerships between the specialised academic establishment with leading clinics, regulatory integration, and funding for translational research could easily position India at the forefront of international players in this field.

Elevate Karnataka: Accelerating Deep-Tech Startups

MEER VERHALEN VAN Bio Spectrum

Bio Spectrum

Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing

Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

NATHEALTH names Dr Sangita Reddy as new President

NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.

time to read

1 min

May 2026

Bio Spectrum

Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap

In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.

time to read

7 mins

May 2026

Bio Spectrum

WHO lays focus on simulation exercises to strengthen health emergency readiness

To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Akrivia Biosciences decodes breast cancer genomic heterogeneity

Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Integrating AI for Tech-driven Ayurveda

A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.

time to read

2 mins

May 2026

Bio Spectrum

ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation

ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.

time to read

1 min

May 2026

Bio Spectrum

MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students

MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Thermo Fisher launches integrated platform to accelerate biologics development

Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.

time to read

1 min

May 2026

Bio Spectrum

Bio Spectrum

Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay

Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.

time to read

1 min

May 2026

Listen

Translate

Share

-
+

Change font size